BHB(BHB)
BHB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $197M | $206M |
| Low | $197M | $205M |
| High | $198M | $207M |
| EBITDA Avg | $48M | $50M |
| Low | $47M | $49M |
| High | $48M | $50M |
| EBIT Avg | $41M | $43M |
| Low | $41M | $43M |
| High | $41M | $43M |
| Net Income Avg | $61M | $64M |
| Low | $60M | $63M |
| High | $61M | $64M |
| EPS Avg | $3.63 | $3.79 |
| Low | $3.60 | $3.76 |
| High | $3.65 | $3.81 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $50M | $51M | $50M | $51M | $52M | $53M |
| Low | $50M | $50M | $50M | $51M | $52M | $52M |
| High | $51M | $51M | $50M | $51M | $53M | $53M |
| EBITDA Avg | $12M | $12M | $12M | $12M | $13M | $13M |
| Low | $12M | $12M | $12M | $12M | $13M | $13M |
| High | $12M | $12M | $12M | $12M | $13M | $13M |
| EBIT Avg | $11M | $11M | $10M | $11M | $11M | $11M |
| Low | $10M | $10M | $10M | $11M | $11M | $11M |
| High | $11M | $11M | $10M | $11M | $11M | $11M |
| Net Income Avg | $16M | $16M | $15M | $16M | $16M | $16M |
| Low | $16M | $16M | $15M | $16M | $16M | $16M |
| High | $16M | $16M | $15M | $16M | $16M | $17M |
| EPS Avg | $0.94 | $0.93 | $0.90 | $0.93 | $0.97 | $0.98 |
| Low | $0.93 | $0.92 | $0.89 | $0.92 | $0.97 | $0.97 |
| High | $0.95 | $0.94 | $0.91 | $0.94 | $0.98 | $0.99 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |